Bhatti Sundus, Kim Donghee, Ahmed Aijaz, Cholankeril George
Baylor College of Medicine, Section of Gastroenterology and Hepatology, 6620 Main Street, Suite 1450, Houston, TX 77030, USA; Baylor College of Medicine, Division of Abdominal Transplantation, Houston, TX, USA.
Stanford University School of Medicine, Division of Gastroenterology and Hepatology, 750 Welch Road, #210, Stanford, CA 94304, USA.
Clin Liver Dis. 2021 Aug;25(3):625-634. doi: 10.1016/j.cld.2021.04.002. Epub 2021 May 29.
Liver transplantation (LT) for alcohol-related or alcoholic hepatitis (AH) remains a controversial treatment option. However, recent studies have shown promising outcomes for LT in a subgroup of patients with AH. Considering these emerging data, LT as definitive therapy for severe AH refractory to medical management is gaining recognition. However, concerns of alcohol recidivism pose a significant barrier to perform LT for this indication. Predictive models can be utilized to develop a selection criterion to identify suitable candidates for LT. Hence, carefully selected patients with severe AH and low risk of alcohol relapse can be considered for LT.
用于酒精相关性或酒精性肝炎(AH)的肝移植(LT)仍然是一种存在争议的治疗选择。然而,最近的研究表明,在一部分AH患者中,LT取得了令人鼓舞的结果。考虑到这些新出现的数据,将LT作为对药物治疗无效的重度AH的确定性治疗方法正逐渐得到认可。然而,对酒精复饮的担忧成为了针对这一适应症进行LT的重大障碍。可以利用预测模型来制定选择标准,以识别适合LT的候选人。因此,对于经过精心挑选的重度AH且酒精复发风险低的患者,可以考虑进行LT。